Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6:NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has a Zacks Rank #1 and...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Alaska Air Group, Inc. ALK: This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:CoreCard Corporation CCRD: This technology solutions and processing services company...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:eGain Corporation EGAN: This customer engagement solutions provider has seen the Zacks Consensus Estimate for its current year earnings...
Previously announced data sharing agreement for intravenous ketamine Newly available data highlight the need for a labeled form of IV ketamine that can qualify...
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...